• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Syntaxin-8 (STX8), Truncated

ACP09902

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09902 Target NameSTX8
Target SynonymsCARB; STX 8; Stx8; STX8_HUMAN; Syntaxin-8; Syntaxin8FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9UNK0
Background Information
  • Uniprot Id

    Q9UNK0

  • Target Species

    Human

  • Target Name

    STX8

  • Target Full Name

    Syntaxin-8

  • Target Function

    Vesicle trafficking protein that functions in the early secretory pathway, possibly by mediating retrograde transport from cis-Golgi membranes to the ER.

  • Target Subcellular Location

    Membrane; Single-pass type IV membrane protein.

  • Target Protein Families

    Syntaxin family

  • Target Tissue Specificity

    Highly expressed in heart. Also found in brain, kidney, liver, lung, placenta, skeletal muscle, spleen and pancreas.

  • Target Synonyms

    CARB; STX 8; Stx8; STX8_HUMAN; Syntaxin-8; Syntaxin8

  • Target Background

    The gene is a member of the syntaxin family. The encoded protein is involved in protein trafficking from early to late endosomes via vesicle fusion and exocytosis. A related pseudogene has been identified on chromosome 12. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Syntaxin-8 (STX8), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification